Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 3/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 9/20 | 0.42 |
| ▸ | KCNN4 | O15554 | 3/20 | 0.41 |
| ▸ | KCNA3 | P22001 | 2/20 | 0.41 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.37 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.37 |
| ▸ | CCKBR | P32239 | 2/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.37 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7789691 | 0.83 | KCNN4 (0.66) | CYP11B1CYP11B2CYP19A1KCNN4KCNA3 | |
| SCHEMBL12989399 | 0.80 | CYP19A1 (0.40) | CYP11B1CYP11B2CYP19A1KCNN4KCNA3 | |
| SCHEMBL11017596 | 0.80 | CYP19A1 (0.40) | CYP11B1CYP11B2CYP19A1KCNN4KCNA3 | |
| SCHEMBL10503507 | 0.73 | KMT2A (0.37) | CYP11B1CYP11B2CYP19A1NOTUMKMT2A | |
| SCHEMBL2392374 | 0.72 | KCNN4 (0.69) | CYP11B1CYP11B2CYP19A1KCNN4KCNA3 | |
| SCHEMBL9945358 | 0.72 | CYP19A1 (0.41) | CYP19A1KCNN4KCNA3NOTUMTBXA2R | |
| SCHEMBL198143 | 0.71 | NOTUM (0.45) | CYP11B1CYP11B2CYP19A1KCNN4KCNA3 | |
| SCHEMBL20514257 | 0.70 | CYP2C19 (0.40) | CYP19A1NOTUMKMT2AMEN1CYP2C19 | |
| SCHEMBL10335454 | 0.67 | CYP19A1 (0.42) | CYP11B1CYP11B2CYP19A1NOTUMKMT2A | |
| SCHEMBL14478094 | 0.65 | CYP11B1 (0.40) | CYP11B1CYP11B2CYP19A1KCNN4KCNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010011137-A1 | Use of triphenylmethyl-1,2,3-triazoles | URBAHNS KLAUS (DE) | 2001-08-02 | — | — | US | disclosed |
| US-20010011137-A1 | Use of triphenylmethyl-1,2,3-triazoles | URBAHNS KLAUS (DE) | 2001-08-02 | — | — | US | disclosed |
| US-20010011137-A1 | Use of triphenylmethyl-1,2,3-triazoles | URBAHNS KLAUS (DE) | 2001-08-02 | — | — | US | disclosed |
| EP-0023286-B1 | AZOLYL-ALKENOLS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES | BAYER AG (DE) | 1983-04-13 | — | — | EP | disclosed |
| US-4360528-A | Combating fungi with 1-azolyl-1-propen-3-ols | BAYER AKTIENGESELLSCHAFT (DE) | 1982-11-23 | — | — | US | disclosed |
| EP-0006538-B1 | SULFENYLATED CARBAMOYL-TRIAZOLYL-O,N-ACETALS, THEIR PREPARATION AND USE AS FUNGICIDES | BAYER AG (DE) | 1981-12-02 | — | — | EP | disclosed |
| EP-0023286-A2 | Azolyl-alkenols, process for their preparation and their use as fungicides | BAYER AG (DE) | 1981-02-04 | — | — | EP | disclosed |
| US-4239766-A | Combating fungi with 1-(4-phenoxy)-3,3-dimethyl-2-(N-halogenoalkylmercapto-carbamoyloxy)-1-(1,2,4-triazol-1-yl)-butanes | BAYER AKTIENGESELLSCHAFT (DE) | 1980-12-16 | — | — | US | disclosed |
| EP-0006538-A1 | Sulfenylated carbamoyl-triazolyl-O,N-acetals, their preparation and use as fungicides | BAYER AG (DE) | 1980-01-09 | — | — | EP | disclosed |
| US-3974174-A | FUNGICIDE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-10 | — | — | US | disclosed |
| US-3972892-A | FUNGICIDE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010011137-A1 | Use of triphenylmethyl-1,2,3-triazoles | PNMT, NLN, TPMT | CYP11B1 33/4885CYP11B2 18/4885CYP19A1 1909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.